Work

RPPA-Profiling Identifies Patients with Low Phosphorylation Levels of HSF1 at Serine 326 As Potential Candidate for Bortezomib Treatment in Addition to Standard Therapy in Pediatric Acute Myeloid Leukemia

Year: 2018

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2018-99-110730

Authors: Fieke W Hoff, Wendy Hu, Yihua Qiu, Alan S Gamis, Richard Aplenc, E. Anders Kolb, Todd A Alonzo, Amina A Qutub, Eveline S. de Bont, Sophia W.M. Bruggeman, Steven M. Kornblau, Terzah M. Horton

Institutions: University Medical Center Groningen, Rice University, The University of Texas MD Anderson Cancer Center, Children's Mercy Hospital, Children's Hospital of Philadelphia, Alfred I. duPont Hospital for Children, University of Southern California, Baylor College of Medicine

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2906755026

Cites:

Cited by: 3

Related to: 10